Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Working Capital/Sales

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023
   Working Capital/Sales(x) 0.791.51

What is the latest Working Capital/Sales ratio of GENPHARMASEC ?

The latest Working Capital/Sales ratio of GENPHARMASEC is 0.79 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20240.79
Mar20231.51

How is Working Capital/Sales of GENPHARMASEC Trending?

Years Working Capital/Sales % Change
Mar2024 0.79
-47.68
Mar2023 1.51 -

Other Financial Ratios of GENPHARMASEC


Compare Working Capital/Sales ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹111.8 Cr NA -8.2% -14.1% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹9,585.1 Cr -1% -2.5% 36.5% Stock Analytics
KIRI INDUSTRIES ₹3,067.4 Cr -0.6% -6.5% 55.3% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹2,047.0 Cr -1.3% -3% -2.3% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,135.4 Cr 5.6% 9.6% 44.2% Stock Analytics
BODAL CHEMICALS ₹949.4 Cr -2% 1% -5.4% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC NA

-8.2%

-14.1%

SENSEX

-1.1%

-0%

3.2%


You may also like the below Video Courses